Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-23-006485
Filing Date
2023-01-11
Accepted
2023-01-11 16:16:40
Documents
8
Effectiveness Date
2023-01-11

Document Format Files

Seq Description Document Type Size
1 S-8 d382609ds8.htm S-8 48864
2 EX-5.1 d382609dex51.htm EX-5.1 7973
3 EX-23.1 d382609dex231.htm EX-23.1 2027
4 EX-99.1 d382609dex991.htm EX-99.1 131539
5 EX-99.5 d382609dex995.htm EX-99.5 120604
6 EX-99.6 d382609dex996.htm EX-99.6 59074
7 EX-FILING FEES d382609dexfilingfees.htm EX-FILING FEES 22270
8 GRAPHIC g382609g0112000124802.jpg GRAPHIC 2409
  Complete submission text file 0001193125-23-006485.txt   396854
Mailing Address 4224 CAMPUS POINT COURT SUITE 210 SAN DIEGO CA 92121
Business Address 4224 CAMPUS POINT COURT SUITE 210 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-269184 | Film No.: 23523763
SIC: 2834 Pharmaceutical Preparations